New Trials for a COVID-19 Vaccine are starting. In Seattle, Washington; the Kaiser Permanente Washington Health Research Institute or ((KPWHRI) just entered phase one in its progress to devise a vaccine.
This study evaluates 45 healthy adults who are are asymptomatic and not ill of the flu, cold, and COVID-19. The experimental study is projected to last for six weeks. At the conclusion, a comprehensive analysis will be conducted.
Primarily, this study reviews the effectiveness of the new vaccine treated at varying dosage levels; every 28 days participants will receive their designated injection. The first participant group will get a lower dosage of the vaccine.
Prior to subsequent trials, results will be provided and participants will return for routine check up. Ultimately, the goals is to ensure they do not experience complications or COVID-19 symptoms due to receiving the dose. In doing so, researchers can determine the safety of the experimental vaccine.
As their is no vaccination currently available to prevent the spread of COVID-19, the results of these trials are important.
If you are an adult in the Seattle area between the ages of 18-55 and you want to help with this important study, please visit http://corona.kpwashingtonresearch.org for more information. Remember, healthy participants are essential to progressing the research of this study.
To learn more about COVID-19, American Medical Compliance offers courses to keep you up to date on important information. American Medical Compliance has helpful manuals to help you stay in the know about many different topics.
To learn more about the manuals, click here:
To learn more about the experimental vaccine, visit: http://www.nih.gov/news-events/news-releases/nih-clinical-trial-investigational-vaccine-covid-19-begins
